Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HFNC vs Venturi Mask in Immunocompromised Patients with ARF
NCT02424773Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Nov 2012
- Primary completion
- Nov 2014
01
Overview
Phase 3, randomised, open-label trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Oxygenation failure at 2 hours. Started Nov 2012; status: completed.
Beyond the preview
Go deeper on NCT02424773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02424773.